Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

By M. Marmor, U. Kellner, T. Lai, R. Melles, W. Mieler. Ophthalmology (Rochester, Minn.), 2016

1,018 citations recorded by the source corpus.

Subfields: Ophthalmology

View Paper: https://www.semanticscholar.org/paper/236a6fa887d7056d3584b9fa27ca8190f0d665aa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Morand
2. R. Furie
3. Jeanette Andersen
4. S. Navarra
5. M. Aringer
6. I. Bruce
7. Maria G. Tektonidou
8. L. Arnaud

Citations in the corpus

• EULAR recommendations for the management of systemic lupus erythematosus: 2023 update (2023, background): “27 Finally, quinacrine can be considered in patients with cutaneous manifestations and HCQ-induced retinopathy.”
• 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis (2020, neutral): “32 56 Dose adjustments (50% reduction) and yearly eye monitoring from onset are recommended for patients with GFR <30 mL/min.”